| P2093 | author name string | Bioulac B | |
| | Lagueny A | |
| | Bonnet B | |
| | Burbaud P | |
| | Guehl D | |
| P2860 | cites work | Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit | Q24321527 |
| | Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism | Q28328337 |
| | Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia | Q28332947 |
| | D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 |
| | Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis | Q30465809 |
| | Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys | Q34061020 |
| | Blockade of excitatory neurotransmission in the globus pallidus induces rigidity and akinesia in the rat: implications for excitatory neurotransmission in pathogenesis of Parkinson's diseases | Q34186358 |
| | Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease | Q40551337 |
| | Physiology of basal ganglia disorders: an overview. | Q40772145 |
| | Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of chorea | Q41400116 |
| | Dystonia in Parkinson's disease: clinical and pharmacological features | Q42213318 |
| | Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. | Q42281245 |
| | Idiopathic cervical dystonia: clinical characteristics | Q44510674 |
| | GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons. | Q47921750 |
| | Basal ganglia motor control. III. Pallidal ablation: normal reaction time, muscle cocontraction, and slow movement | Q47937495 |
| | Effects of reversible blockade of basal ganglia on a voluntary arm movement | Q48410358 |
| | Subcortical changes in the regional uptake of [3H]-2-deoxyglucose in the brain of the monkey during experimental choreiform dyskinesia elicited by injection of a gamma-aminobutyric acid antagonist into the subthalamic nucleus | Q48482417 |
| | The behavioural and motor consequences of focal lesions of the basal ganglia in man. | Q51132485 |
| | Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop | Q56093340 |
| | Dyskinesia in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidus | Q69337533 |
| | A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis) | Q70325126 |
| | Bilateral subthalamic nucleus stimulation for severe Parkinson's disease | Q70875241 |
| | Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus | Q71323710 |
| | The atypical neuroleptic, clozapine, exerts antidystonic activity in a mutant hamster model. Comparison with haloperidol | Q72709426 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | substantia nigra | Q753278 |
| | movement disorders | Q2608695 |
| P304 | page(s) | 102-107 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Movement disorders induced by gamma-aminobutyric agonist and antagonist injections into the internal globus pallidus and substantia nigra pars reticulata of the monkey | |
| P478 | volume | 780 | |